Chapter 575

"Yes, boss, and I have a new idea. Boss, you can ask Biyi group to increase the proportion of investment in biopharmaceutical research, and let them invest more angel investment funds to invest in biological R & D teams and individuals who have ideas but have no funds to carry out laboratory specific experiments, and let them do their own research!

No matter whether they can work out any achievements, we are more happy to have the results, we can continue to increase investment, and there is no need to be disappointed if there are no concrete results.

Because even if their research is wrong, or there is no profit from the results, their research data and R & D process is not a small gain, at least it can let our company's headquarters take a lot of detours and save more R & D time!

I think with the development speed of Biyi group and the support of your boss, it is very easy for them to invest 5 billion US dollars in the field of biopharmaceuticals every year.

And our company can also let our angel investment department make angel investment in the field of biopharmaceuticals. The funds here are more abundant, and there is no problem to invest $10 billion every year!

With more than 15 billion US dollars invested each year, we can basically make global investment in many biopharmaceutical fields!

These investments can bring huge R & D data to the company. After these data are integrated by the company, the company's R & D database can become very substantial, so that the company has more data support for related R & D!

We can also use our own private funds to invest in related fields. The day-to-day investment management company I am in charge of can be responsible for the investment work in this respect. With our current capital scale, it is also a matter of pouring water into another 15 billion US dollars of investment!

This fund can be invested in those companies and countries that are hostile to us. With a little money, they can help us carry out research and development in the field of biopharmaceuticals. I'm glad to think about it!

In this way, we will invest more than 30 billion US dollars in angel investment every year, which will greatly promote the R & D process in the field of biopharmaceuticals!

After all, the amount of our investment is more than the total annual investment in the field of biopharmaceuticals in the world. It would be strange if such a large amount of investment could not promote the R & D process in related fields!

After all, our investment is not a completely profit seeking investment. There is little way to obtain angel investment for some biological R & D work without profit. However, the research abandoned by capital is also very valuable for us!

For example, boss, you know that the hot spot of investment in the field of biopharmaceuticals is in the research of new drugs related to anticancer drugs. Few pharmaceutical companies conduct research on the research and development of some minor diseases. Even if there are, large companies will only do it after receiving state subsidies, and the drugs developed are all sky high price drugs!

However, no one is willing to study more minority diseases, because even if such research is out, there are not many benefits. Few people are willing to do the business of capital chasing profits and losing money!

However, our company can carry out relevant investment work on these minority diseases in the external angel investment. On the one hand, this can increase the social impact of our company. On the other hand, I think the research on these minority diseases is also very important!

These unknown diseases caused by genetic diseases, which are still very unfamiliar to the field of biopharmaceuticals, or the known diseases with only tens of thousands of patients, I think if we can carry out more research on their genetic diseases, we will be able to more accurately grasp our own genes.

In addition, it can carry out more in-depth research on how to solve the real gene lesions, which will bring more data and R & D experience to our company's future research work in response to more complex space gene lesions.

This is very important for the future of the company. After all, in the space environment, it is possible for us to have any mutation in human genes. If we do not have the research preparation in this field, we will suffer in the future!

This is my idea. I hope boss, you can let our company's biopharmaceutical research involve experts from all over the world, and the research of these people will also enable our company's biopharmaceutical companies to get huge data feedback and maintain their greatest enthusiasm for work. After all, there are so many competitors outside who are also engaged in relevant research If you don't work hard, you will be eliminated! "

Kuafu introduced his idea in detail. His idea also proved that his wisdom has been able to think independently. This is an incredible thing for artificial intelligence, but it is a very normal thing for intelligent life. Once again, Kuafu can be regarded as a primary intelligent life!

"Good! Kuafu, your idea is very good! Although $30 billion a year is not a small figure, we can still afford it. Moreover, it does not mean that all these investments will be wasted and there will always be profits in the future. Maybe some investment will bring us surprise!In any case, angel investment is such a thing. As long as one of the 100 projects can succeed, it can make up for the loss. If there are more successful projects, we can make money. For the later investment, we may only need to invest 10 billion US dollars a year at most!

I think we will lose 10 billion US dollars every year at most. We can still afford to lose this money. Moreover, the R & D data in these investments is our biggest gain. I think it is very valuable to buy these R & D data with a loss of US $10 billion per year!

Then our own investment will be handed over to your daily investment management company. I will explain it to Biyi group. As for the company, I will account to Jiang Yuting! " Lei Tiantang said happily.

Biopharmaceuticals refer to the application of the research results of Microbiology, biology, medicine and biochemistry, from organism, biological tissue, cell, organ, body fluid, etc. It is a kind of product for prevention, treatment and diagnosis, which is made by using the principles and methods of Microbiology, chemistry, biochemistry, biotechnology and pharmacy.

There are too many research categories involved in this field. If we rely on a biopharmaceutical company set up in Lei Tiantang's plan to conduct research, only heaven knows when we can achieve results.

www.novelhall.com , the fastest update of the webnovel!